Cagrilintide
About Cagrilintide
Cagrilintide is a long-acting amylin analog designed for once-weekly subcutaneous dosing. It activates amylin receptors in the brainstem to reduce appetite, slow gastric emptying, and promote satiety. When combined with semaglutide (as CagriSema), clinical trials have shown up to 22.7% weight loss, making it a leading next-generation obesity treatment.
Vendor Comparison — 0 vendors
Peptide Index may earn a commission if you purchase through links on this page.
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog designed for once-weekly subcutaneous dosing. It activates amylin receptors in the brainstem to reduce appetite, slow gastric emptying, and promote satiety. When combined with semaglutide (as CagriSema), clinical trials have shown up to 22.7% weight loss, making it a leading next-generation obesity treatment.
Where can I buy Cagrilintide?
0 vendors sell Cagrilintide. Compare prices and ratings in the vendor comparison table above. Peptide Guide is the featured vendor with Bitcoin and XRP payment options.